CYAD - Celyad Oncology GAAP EPS of -Euro1.70
Celyad Oncology press release (NASDAQ:CYAD): FY GAAP EPS of -€1.70. Cash position of €30.0 million ($34.0 million) as of December 31, 2021
For further details see:
Celyad Oncology GAAP EPS of -€1.70Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Celyad SA |
| Stock Symbol: | CYAD |
| Market: | NASDAQ |
Get CYAD Alerts
News, Short Squeeze, Breakout and More Instantly...